Sildenafil
Product Images NDC 59762-2058

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 59762-2058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Greenstone Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sildenafil 01)

An instructional diagram showing a liquid medication bottle with a dropper and a dosing syringe with volume markings, labeled with 'x 1' indicating a single dose. The illustration likely relates to Sildenafil, manufactured by Greenstone LLC, demonstrating how to measure or administer a specific liquid dose.*

FDA Label Image

Figure 2 (Sildenafil 02)

Instructional illustration showing how to prepare a liquid medication bottle by first pressing down and turning the cap to open it, then shaking the bottle in a back-and-forth and up-and-down motion, accompanied by a stopwatch indicating a 30-second duration for shaking. The image is related to preparation steps for a Sildenafil liquid formulation by Greenstone LLC.*

FDA Label Image

Figure 3 (Sildenafil 03)

An instructional illustration depicting a volume measurement cylinder next to an opened bottle, with a marked syringe positioned above the bottle as if drawing liquid from it. The syringe is labeled with volume markings and a quantity of 1 is indicated, suggesting the measurement and withdrawal of a liquid dose.*

FDA Label Image

Figure 4 (Sildenafil 04)

An instructional diagram showing three steps: pressing down and turning a bottle cap to open it, shaking the bottle by moving it up and down and side to side, and a stopwatch indicating a 30-second waiting period. The image relates to proper handling of a liquid medication bottle.*

FDA Label Image

Figure 5 (Sildenafil 05)

An instructional diagram showing how to open a bottle with a child-resistant cap. The first image demonstrates pressing down on the cap while aligning it to open, and the second image shows twisting the cap to the left while pressing down on it to remove it. The bottle is unlabeled, and no product-specific text is visible.*

FDA Label Image

Figure 6 (Sildenafil 06)

A line chart showing estimated cumulative mortality rate (%) over time in years for three different dose groups labeled High Dose, Medium Dose, and Low Dose. The y-axis represents mortality rate from 0 to 25%, and the x-axis shows time from 0 to 5 years. The chart includes stepwise lines for each dose group with a corresponding count of patients at risk at various time points displayed above the graph.*

FDA Label Image

Chemical Structure (Sildenafil 07)

Chemical structure diagram of Sildenafil, illustrating its molecular components including aromatic rings, nitrogen-containing heterocycles, and functional groups such as sulfonamide and carboxyl groups.*

FDA Label Image

Figure 7 (Sildenafil 08)

A clinical drug interaction chart depicting the fold change and 90% confidence interval of area under the curve (AUC) and maximum concentration (Cmax) of Sildenafil when coadministered with various interacting drugs. The graph includes Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, along with dosing adjustment recommendations.*

FDA Label Image

Figure 8 (Sildenafil 09)

A forest plot chart depicting the fold change and 90% confidence intervals for various pharmacokinetic parameters such as INR, AUC, Cmax, and BT when sildenafil is administered with different interacting drugs. The chart includes recommendations for dose adjustment, mostly indicating no dose adjustment needed except for ritonavir where coadministration is not recommended. The x-axis represents change relative to the interacting drug alone, centered at 1.*

FDA Label Image

Figure 9 (Sildenafil 10)

A line graph comparing changes from baseline in meters over the weeks of a study (Weeks 4, 8, and 12). The graph shows data for Placebo, Sildenafil 20mg TID, 40mg TID, and 80mg TID dosing groups with error bars indicating variability. The y-axis represents change from baseline in meters, and the x-axis represents the week of study.*

FDA Label Image

Figure 10 (Sildenafil 11)

A forest plot displaying placebo-corrected changes in 6-minute walk distance associated with Sildenafil 20 mg TID across various subgroups. Subgroups include baseline walk distance, etiology of pulmonary arterial hypertension (PAH), PH functional class, gender, age, mean pulmonary artery pressure (PAP), and pulmonary vascular resistance index (PVRI). The chart compares placebo and Sildenafil groups with confidence intervals for each subgroup.*

FDA Label Image

Figure 11 (Sildenafil 12)

A line chart comparing the percentage of subjects without a clinically worsening event over days from randomization for Sildenafil versus placebo. The x-axis shows days from 0 to 112, and the y-axis shows the percentage from 0 to 100. Sildenafil appears as a dotted line maintaining a higher percentage without clinical worsening than the solid placebo line.*

FDA Label Image

Figure 12 (Sildenafil 13)

Line chart depicting the mean change from baseline (meters) over a 12-week study period for Sildenafil at doses of 1 mg TID, 5 mg TID, and 20 mg TID. The vertical axis shows change from baseline in meters, and the horizontal axis shows weeks 4, 8, and 12. Error bars represent the standard error for each treatment group at each visit.*

FDA Label Image

Logo (Sildenafil 14)

FDA Label Image

Logo (Sildenafil 15)

The image shows a label section for Greenstone Brand, indicating distribution by Greenstone LLC located in Peapack, NJ 07977. The label prominently features the Greenstone logo and branding information, with no specific product details visible.*

FDA Label Image

Figure A (Sildenafil 16)

Illustration of a sildenafil oral suspension bottle with a cap and syringe adaptor on the left, and a separate syringe on the right labeled with its components: tip, barrel, and plunger. The bottle is partially filled with the suspension.*

FDA Label Image

Figure B (Sildenafil 17)

An instructional diagram showing three steps for handling a bottle: gripping and rotating the cap, waiting for a stopwatch timer to reach about 10 seconds, and pushing down while twisting the cap to open the bottle. No product-specific text is visible.*

FDA Label Image

Figure C (Sildenafil 18)

An instructional diagram showing a person using a dropper to fill from a bottle, demonstrating how to measure liquid medication. The image highlights hand placement and proper use of the dropper in a step-by-step style.*

FDA Label Image

Figure D (Sildenafil 19)

An instructional illustration showing a hand holding a bottle upside down while drawing liquid into a syringe. The syringe is marked with volume measurements in milliliters. An arrow indicates the direction to pull the syringe plunger down to draw fluid.*

FDA Label Image

Figure E (Sildenafil 20)

An instructional illustration showing a syringe insertion into a vial. The image depicts the syringe plunger being pulled upwards, indicating the step to withdraw liquid from the vial, likely as part of medication preparation or administration.*

FDA Label Image

Figure F (Sildenafil 21)

An instructional illustration showing a syringe positioned at the corner of a person's mouth, demonstrating an oral administration technique.*

FDA Label Image

Figure G (Sildenafil 22)

An instructional diagram showing a faucet with water flowing into two syringes, one labeled 10 mL and the other 20 mL, illustrating measurement or filling of liquid volumes.*

FDA Label Image

Logo (Sildenafil 23)

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Sildenafil tablets 20 mg by Greenstone LLC, presented on a label showing the Greenstone brand name. The label states quantity as 90 tablets and includes storage instructions for controlled room temperature and dosage use reference. It is marked Rx only and made in Ireland.*

FDA Label Image

Principal Display Panel (10 mg/mL Bottle Label)

Sildenafil 10 mg/mL oral suspension label by Greenstone LLC. The label includes storage instructions before and after reconstitution, dosage information, and mentions the suspension is grape flavored. It specifies the volume as 112 mL following reconstitution and indicates the product is for oral use only and Rx only. The label also shows the NDC 59762-2058-1 and states the product is made in Ireland.*

FDA Label Image

Principal Display Panel (10 mg/mL Bottle Carton)

Sildenafil 10 mg/mL oral suspension carton from Greenstone LLC. The label indicates the product is grape flavored and provides 112 mL following reconstitution. The label includes storage, reconstitution, and dosage instructions, barcode, NDC 59762-2058-1, and states the product is for oral use only and Rx only. The packaging is marked made in Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.